Name | Type | Posted | Actions |
|---|---|---|---|
Notice of Intent.pdf | Apr 27, 2026 |
NovaSeq X Series 25B Reagent Kits
Contact and place of performance
David Shen
Bethesda, MD 20892
USA
Attachment: Notice of Intent
The National Institutes of Health, Office of Logistics and Acquisition Operations (OLAO), issued this pre-solicitation notice under solicitation number 75N98026Q00260 for the procurement of NovaSeq X Series 25B Reagent Kits. This requirement falls under NAICS code 325414 for Biological Product (except Diagnostic) Manufacturing and PSC 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. There is no set-aside designated for this acquisition.
The primary objective of this notice is to communicate the agency's intent to acquire specialized reagent kits to support genomic sequencing operations. Performance will take place in Bethesda, Maryland. Detailed information regarding the acquisition strategy is contained within a single attachment titled "Notice of Intent.pdf" which was published on April 27, 2026.
Submissions regarding this requirement are due by the response deadline of May 7, 2026. David Shen serves as the primary point of contact for this notice. All activities related to this procurement are managed by the National Institutes of Health.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.